PEAK6’s CONMED CNMD Stock Holding History

PEAK6’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3,846	Closed	-$200K	–	3005
2025 Q2	$200K	Sell	3,846 -3,625	-49%	-$199K	﹤0.01%	2449
2025 Q1	$451K	Buy	7,471 +4,137	+124%	+$267K	﹤0.01%	2127
2024 Q4	$228K	Buy	+3,334	New	+$232K	﹤0.01%	2493

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

PEAK6's CNMD Position: Q3 2025 in Review

PEAK6 sold out of CONMED (CNMD) in Q3 2025, closing a stake of 3,846 shares — an estimated $200K sold.

PEAK6 first reported a position in CNMD in Q4 2024 and held it in 3 quarters. The position peaked at $451K in Q1 2025. 273 funds tracked by Wall St. Rank hold CNMD as of Q3 2025.

PEAK6 reported no remaining CONMED position as of Q3 2025 after selling out during the quarter.
PEAK6 sold 3,846 CONMED shares in Q3 2025, an estimated $200K.
PEAK6 first reported a position in CONMED in Q4 2024 and held it in 3 quarters.
PEAK6's CONMED position peaked at $451K in Q1 2025.
273 funds tracked by Wall St. Rank held CONMED as of Q3 2025.

Based on PEAK6's 13F filing for Q3 2025, filed 14 Nov 2025.